ST JOHN'S WORT

CAS No.
Chemical Name:
ST JOHN'S WORT
Synonyms
ST JOHN'S WORT;ST JOHN'S WORT OIL
CBNumber:
CB4195236
Molecular Formula:
Molecular Weight:
0
MDL Number:
MFCD01767483
MOL File:
Mol file

ST JOHN'S WORT Properties

NCI Dictionary of Cancer Terms St. John's wort
FDA UNII UFH8805FKA
NCI Drug Dictionary St. John's wort

ST JOHN'S WORT Chemical Properties,Uses,Production

Occurrence

St. John's wort is found in Europe, Asia, and the United States.

Uses

St. John's wort is used to treat mild to moderate depression and anxiety. It may be used topically as an antiinfl ammatory to relieve hemorrhoids, as well as to treat vitiligo and burns.

Indications

St. John’s wort (Hypericum perforatum) is a yellowflowered perennial European herb that has become widely naturalized in the United States. Its name is derived from the Old English word for plant, wort, and from the fact that it often starts blooming around June 24, St. John’s day. Although St. John’s wort has traditionally been used for wound healing, insomnia, rheumatism, and depression, it is most popular today for the treatment of mild to moderate depression.
The leafy parts of the herb contain naphthodianthrones (e.g., hypericin), flavonoids (e.g., quercetin), and phloroglucinols (e.g., hypaphorine). Although this herb is now commonly standardized for its hypericin content, it appears that its other constituents may also be just as pharmacologically active.

Mechanism of action

Just how St. John’s wort treats depression is not clearly understood. It is possible that this herb’s various components may work synergistically rather than through a single active substance, mimicking the action of traditional antidepressants. High concentrations can affect in vitro serotonin reuptake, but it is unclear whether this would occur in a patient taking standard oral doses.The hypaphorine constituent may possess serotonin reuptake inhibitor activity, and it also inhibits synaptic uptake of  amino butyric acid (GABA) and L-glutamate. Earlier studies demonstrated some monoamine oxidase inhibition, but this action now seems unlikely to be clinically relevant. Flavonoid components and hypericin also may weakly inhibit catechol-O-methyl-transferase (COMT). Melatonin, surprisingly, has also been identified in St. John’s wort and may play a role in its sleepenhancing and antidepressant effects.

Clinical Use

St. John’s wort is very popular as a physician-prescribed antidepressant in Europe and is widely used for this purpose—usually without medical guidance—in the United States.A meta-analysis of 23 studies concluded that St. John’s wort was more effective than placebo in treating mild to moderate depression and was as effective as imipramine and standard antidepressants. It was also better tolerated than the antidepressants to which it was compared. A recent meta-analysis, however, failed to find St. John’s wort effective for severe depression.

Side effects

St. John’s wort is usually well tolerated, but insomnia, dizziness, fatigue, restlessness, GI upset, constipation, dry mouth, and allergy are reported as possible side effects. Hypomania has also been reported in several cases, and rarely, photosensitivity can be a problem following high doses; hypericin seems to be the component responsible for the photosensitivity. Sun-induced neuropathy has also been described, and it is possible that hypericin may also increase the risk of cataracts with prolonged use.While a prior allergy to the herb is the main contraindication, St. John’s wort should also be avoided in pregnant and breast-feeding women (it may increase uterine tone) and in children until its safety is further established.
A major emerging concern in St. John’s wort use is the numerous clinically significant herb–drug interactions that have been reported. St. John’s wort appears to be a major inducer of the cytochrome P450 3A4 (CYP3A4) enzyme system in the liver.This first came to light following acute heart transplant rejection in a person taking cyclosporin and St. John’s wort. The cyclosporin levels remained subtherapeutic until St. John’s wort was discontinued. A similar phenomenon was noted with AIDS patients taking protease inhibitors and nonnucleoside reverse transcriptase inhibitors (NNRTIs). Concomitant use of St. John’s wort reduced the effectiveness of these medicines as well. Since then, St. John’s wort has been shown to reduce plasma levels of digoxin, warfarin, theophylline, and oral contraceptives. Breakthrough bleeding has been observed in young women taking this herb, and patients starting oral contraceptives should be counseled to use backup contraception if they take St. John’s wort or antibiotics. St. John’s wort can adversely affect many other common medications, including nonsedating antihistamines, antifungals, chemotherapeutic agents, and calcium channel blockers.
SSRIs should not be taken with St. John’s wort because of the risk of the onset of a serotonin syndrome characterized by nausea, tremor, and weakness.Alcohol also should be avoided. St. John’s wort can increase opioid-induced sleep.

ST JOHN'S WORT Preparation Products And Raw materials

Raw materials

Preparation Products

ST JOHN'S WORT Suppliers

Global( 11)Suppliers
Supplier Tel Email Country ProdList Advantage
Jiangxi Planty Manor Health Industry Co., Ltd. 0796-18507969315 18507969315 3686433662@qq.com China 436 58
ST JOHN'S WORT OIL ST JOHN'S WORT